Skip to content
lifestyle.realie.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
4basebio
Final Results and Notice of AGM
May 24, 2026
4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial
May 24, 2026
4basebio Announces Appointment of Chief Financial Officer and Board Changes
May 23, 2026
4basebio Launches Enzymatic ssDNA Platform
May 22, 2026
4basebio announces major expansion to support the growing demand of RUO and HQ synthetic DNA with lease of an innovation hub and manufacturing facility in Cambridge, UK
March 31, 2026
4basebio strengthens commercial leadership, promoting Christine Wolosin to Chief Commercial Officer
March 3, 2026
Leadership Changes
February 10, 2026